Sarah Haverin

Sarah Haverin currently serves as the Senior Vice President of Business Development at ELIQUENT Life Sciences, a position attained in July 2022 following the company's acquisition by private equity, where responsibilities include strategic leadership, sales forecasting, and team development. Previously, Sarah was the Vice President of Business Development at Oriel STAT A MATRIX, driving growth in the medical device and IVD sector from January 2015 to July 2022. Early career roles included Business Development Manager at Emergo Group and Senior Research Associate at Monash University, where research focused on critical therapeutic areas. Sarah holds an MBA in International Business from Texas State University and a Bachelor's degree in Genetics, Microbiology, and Molecular Biology from Monash University.